Photo of Kat Cammack
R United States House · District 3 · Florida On the 2026 ballot

Rep. Kat Cammack

Compare
Total votes
2,837
all sessions
Attendance
98%
70 missed
Near the chamber average
With party
91%
of cast votes
Lower than 87% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 85% of chamber peers
Sponsored
780
bills & resolutions
Lower than 82% of chamber peers
Committees
6
assignments
780 bills and resolutions

Sponsored bills

Total
780
Primary
62
Co-sponsor
718
This page
780
matching current filters
Co-sponsor HR 2407
In committee · Delaware House · Co-sponsor
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Maddy summaryThis bill would require Medicare to cover FDA-approved blood tests that screen for multiple cancers simultaneously (like breast, lung, or colorectal cancer) for beneficiaries. It directly affects Medicare recipients aged 65+ who could access these new screenings once per year, without prior authorization. The key provision adds "multi-cancer early detection screening tests" to Medicare's covered services under Part B, defining them as blood tests analyzing cell-free DNA, while maintaining existing coverage for standard screenings like mammograms. The bill does not change current coverage for individual cancer screenings but ensures Medicare keeps pace with new medical technology.

In committee Dec 17, 2024 1 co-sponsor
Co-sponsor HR 2377
In committee · Delaware House · Co-sponsor
Saving Access to Laboratory Services Act

Maddy summaryThis bill modifies Medicare's rules for clinical laboratory testing to reduce administrative burdens. It requires the use of statistically valid sampling (instead of full reporting) for "widely available" tests - defined as tests costing under $1,000 per test with over 100 labs performing them - to determine payment rates starting in 2026. The bill also delays reporting deadlines until 2027, updates how labs are defined for payment purposes, and adds annual payment increase caps (2.5% for common tests in 2024-2025, rising to 5% by 2028). These changes directly affect Medicare-participating labs, particularly independent and hospital-based labs conducting common tests.

In committee Dec 17, 2024 1 co-sponsor
Co-sponsor HR 1526
In committee · Delaware House · Co-sponsor
Reducing Hereditary Cancer Act

Maddy summaryThis bill expands Medicare coverage for hereditary cancer prevention and management. It requires Medicare to cover genetic testing for individuals with a personal or family history of hereditary cancer mutations, as defined by evidence-based guidelines from organizations like the National Comprehensive Cancer Network. The bill also mandates coverage for risk-reducing surgeries (like mastectomies or oophorectomies) when medically appropriate, and increases the frequency of recommended cancer screenings (such as mammograms, colonoscopies, and breast MRI) to at least annually for those with confirmed hereditary cancer gene mutations. These changes apply to Medicare beneficiaries with specific hereditary cancer risk factors, effective upon the bill's enactment.

In committee Dec 17, 2024 1 co-sponsor
Co-sponsor HR 497
Passed · Delaware House · Co-sponsor
Freedom for Health Care Workers Act

Maddy summaryHR 497, the Freedom for Health Care Workers Act, eliminates a federal requirement for healthcare workers in Medicare and Medicaid programs to be vaccinated against COVID-19. The bill directly affects healthcare providers who treat patients under these federally funded programs by preventing the enforcement of the November 2021 HHS rule mandating staff vaccinations. Its key provision prohibits the Department of Health and Human Services from implementing, enforcing, or creating a similar rule regarding vaccination for these workers. This bill changes the policy by removing a specific vaccine mandate for providers in Medicare and Medicaid programs.

Passed Dec 17, 2024 1 co-sponsor
Co-sponsor HR 407
In committee · Delaware House · Co-sponsor
Protect the UNBORN Act

Maddy summaryHR 407, the "Protect the UNBORN Act," prohibits federal agencies from implementing or enforcing two specific executive orders issued by President Biden in 2022 (Executive Orders 14076 and 14079), which aimed to protect access to reproductive healthcare services. The bill bans the use of federal funds, including those from the 2022 Consolidated Appropriations Act, to carry out, administer, or enforce these executive orders. It directly affects federal agencies and programs that would otherwise comply with the Biden administration's policies on reproductive healthcare access. The bill does not create new healthcare rules but blocks the implementation of existing executive actions.

In committee Dec 17, 2024 1 co-sponsor
Co-sponsor HR 7
In committee · Delaware House · Co-sponsor
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023

Maddy summaryThis bill bans federal funding for abortions in most cases, prohibiting the use of taxpayer money for abortion services or health insurance plans covering abortion. Exceptions allow funding for abortions resulting from rape, incest, or when a pregnancy endangers a woman's life. It requires health insurance plans sold through the Affordable Care Act (ACA) marketplaces to clearly disclose any separate costs for abortion coverage and prohibits ACA subsidies from being used for plans that cover abortion (except in the specified exceptions). The law directly affects federal programs like Medicaid, ACA marketplace plans, and insurers offering health coverage to individuals using federal subsidies.

In committee Dec 17, 2024 1 co-sponsor
Co-sponsor HR 152
In committee · Delaware House · Co-sponsor
Hearing Protection Act

Maddy summaryHR 152, titled the "Hearing Protection Act," actually addresses firearm silencers (suppressors), not hearing protection. The bill removes federal registration requirements for silencers by directing the Attorney General to destroy all existing silencer records within 365 days. It also preempts state laws that tax, register, or impose recordkeeping requirements on silencers, making such state rules unenforceable. Additionally, the bill updates tax codes to include silencers as taxable items and clarifies their definition in firearm laws.

In committee Dec 17, 2024 1 co-sponsor
Co-sponsor HR 7137
In committee · Delaware House · Co-sponsor
Trafficking Survivors Relief Act of 2024

Maddy summaryThe Trafficking Survivors Relief Act of 2024 enables victims of human trafficking to seek to vacate certain convictions or expunge arrests related to offenses they committed as a direct result of being trafficked. It establishes a court process where victims can file motions showing their criminal activity was trafficking-related, with courts required to find by preponderance of evidence that the offense was directly tied to trafficking. If granted, the court must expunge all related records, return any fines paid, and treat the individual as if the offense never occurred. The bill also adds a "human trafficking defense" that creates a presumption of duress for trafficking victims in prosecutions. It requires reports on implementation and training for U.S. attorneys on trafficking indicators.

In committee Dec 11, 2024 1 co-sponsor
Primary HR 8450
In committee · Delaware House · Lead sponsor
Phosphate and Potash Protection Act of 2024

Maddy summaryHR 8450, the Phosphate and Potash Protection Act of 2024, directs the Secretary of the Interior (with the Secretary of Agriculture) to evaluate potash and phosphates - minerals essential for fertilizer production - for potential designation as "critical minerals" under federal law. Within 30 days of enactment, the Secretary must assess if these minerals meet the criteria for critical minerals designation, and by 90 days, submit recommendations to support domestic production and a report on the evaluation. If the minerals meet the criteria, they would be added to the official critical minerals list, potentially unlocking federal support for their domestic mining and processing. This bill directly affects mineral producers and the agricultural sector, as critical minerals status can streamline permitting and encourage domestic supply chains for fertilizers.

In committee Dec 10, 2024 0 co-sponsors
Co-sponsor HR 2672
Passed · Delaware House · Co-sponsor
FEMA Loan Interest Payment Relief Act

Maddy summaryThe FEMA Loan Interest Payment Relief Act requires FEMA to reimburse local governments and electric cooperatives for interest paid on qualifying disaster recovery loans. A qualifying loan must be used for FEMA-covered activities with at least 90% of proceeds dedicated to those purposes. Reimbursement covers the lesser of actual interest paid or what would have been paid at the prime interest rate, as defined by the Federal Reserve. This relief applies to interest accrued in the seven years preceding the bill's enactment.

Passed Dec 10, 2024 1 co-sponsor
Showing 191 to 200 of 780 bills
Previous 1 … 19 20 21 … 78 Next